ABSTRACT
We performed a service-based epidemiological study of primary blepharospasm in the island of Sardinia (Italy). Due to its favorable geographical location, we are confident we will provide reliable data from patients seeking botulinum toxin treatment. A total of 53 patients were assessed. Prevalence was estimated to be 32.2 per 1 million (95% confidence interval, 23.0-40.8). These results are in line with those obtained in other similar surveys, that is, record-based, and performed in various European regions such as Northern England, the Munich area, as well as the Epidemiologic Study of Dystonia in Europe.
Subject(s)
Blepharospasm/epidemiology , Adult , Age Factors , Aged , Anti-Dyskinesia Agents/therapeutic use , Blepharospasm/drug therapy , Botulinum Toxins/therapeutic use , Confidence Intervals , Cross-Sectional Studies , Data Collection , Female , Humans , Italy/epidemiology , Male , Middle Aged , Prevalence , Sex FactorsABSTRACT
We report on a patient with persistent abnormal shoulder posture associated with isolated neurogenic hypertrophy of the trapezius muscle due to accessory nerve injury. The patient complained of marked difficulty in shoulder elevation and abduction. Over 6-month treatment with botulinum toxin, there was a complete resolution.
Subject(s)
Accessory Nerve Injuries , Dystonia/etiology , Dystonia/physiopathology , Shoulder/physiopathology , Adult , Botulinum Toxins, Type A/therapeutic use , Diagnosis, Differential , Dystonia/drug therapy , Humans , Lipoma/surgery , Male , Neck , Neoplasms, Adipose Tissue/surgery , Neuromuscular Agents/therapeutic use , Postoperative Complications , Posture/physiologyABSTRACT
We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type-A injection.
